How have LABD shares performed in 2024?

Direxion Daily S&P Biotech Bear 3x Shares' stock was trading at $9.69 at the beginning of the year. Since then, LABD shares have increased by 6.8% and is now trading at $10.35. View the best growth stocks for 2024 here .

What does LABD invest in?

Direxion Daily S&P Biotech Bear 3x Shares is a equity fund issued by Direxion. LABD focuses on health care investments and follows the S&P Biotechnology Select Industry Index. The fund's investments total to approximately $131.24 million assets under management.

What is the management fee for Direxion Daily S&P Biotech Bear 3x Shares?

Direxion Daily S&P Biotech Bear 3x Shares' management fee is 0.75% and has other expenses of 0.26%. However, LABD has a fee waiver of -0.01% to reimburse the expenses. The net expense ratio for LABD is 1.00%.

When did Direxion Daily S&P Biotech Bear 3x Shares' stock split?

Shares of Direxion Daily S&P Biotech Bear 3x Shares reverse split on Friday, August 28th 2020. The 1-20 reverse split was announced on Monday, July 27th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 27th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Direxion Daily S&P Biotech Bear 3x Shares own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Direxion Daily S&P Biotech Bear 3x Shares investors own include Direxion Daily S&P Biotech Bull 3x Shares (LABU) , Micron Technology (MU) , Intel (INTC) , Gilead Sciences (GILD) , Inovio Pharmaceuticals (INO) , NVIDIA (NVDA) , Pfizer (PFE) , Direxion Daily Semiconductors Bull 3x Shares (SOXL) and ProShares UltraPro Short QQQ (SQQQ) .

How do I buy shares of Direxion Daily S&P Biotech Bear 3x Shares?

Shares of LABD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSEARCA:LABD

Direxion Daily S&P Biotech Bear 3x Shares (LABD) Price, Holdings, & News

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free LABD Stock Alerts

$10.45

+0.37 (+3.67%)

(As of 03:09 PM ET)

Compare

Today's Range: $10.01
▼
$10.46
50-Day Range: $5.90
▼
$10.08
52-Week Range: $5.72
▼
$29.92

Volume: 12.97 million shs
Average Volume: 15.70 million shs
Market Capitalization: $153.82 million

Assets Under Management: $131.24 million
Dividend Yield: 0.86%
Net Expense Ratio: 1.00%

Stock Analysis Chart Holdings Ownership

Get Direxion Daily S&P Biotech Bear 3x Shares alerts:

About Direxion Daily S&P Biotech Bear 3x Shares

The Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index. LABD was launched on May 28, 2015 and is managed by Direxion.

LABD Stock Price History

30 days | 90 days | 365 days | Advanced Chart

LABD ETF News Headlines

March 21, 2024 | msn.com

Direxion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0664

March 2, 2024 | msn.com

SOXS, ARKB and LABD among weekly ETF movers

April 18, 2024 | Weiss Ratings (Ad)

This Little-Known Stock Controls the Future of AI

#1 AI Stock for 2024 Revealed In "AI Town Hall" This AI company just signed a deal with NVIDIA that went unreported by the media. Find out how you can get in on what is being dubbed 'the #1 AI stock for 2024 to buy now'

July 21, 2023 | msn.com

LABD: 3X Leveraged Inverse Fund In Biotechnology Sector Is Best Avoided

June 22, 2023 | msn.com

Direxion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0998

June 22, 2023 | msn.com

5 Factors Why Inverse ETFs May Rule in 2H23

March 1, 2023 | msn.com

5 Best Inverse-Leveraged ETFs of February

February 24, 2023 | finance.yahoo.com

This Year's Most Shorted ETFs

April 18, 2024 | Weiss Ratings (Ad)

This Little-Known Stock Controls the Future of AI

February 15, 2023 | finance.yahoo.com

5 Least-Hurt Biotech ETFs of the Last Week

See More Headlines

Receive LABD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bear 3x Shares and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer: Direxion
Fund Name: Direxion Daily S&P Biotech Bear 3x Shares
Tax Classification: Regulated Investment Company
Stock Exchange: NYSEARCA
Current Symbol: NYSEARCA:LABD
Inception Date: 5/28/2015
Fund Manager: Paul Brigandi, Tony Ng
Web: N/A
Phone: N/A

Fund Focus

Asset Class: Equity
Benchmark: S&P Biotechnology Select Industry Index
Category: Sector
Focus: Health Care
Development Level: Developed Markets
Region: North America
Number of Holdings: 25

Fund Statistics

Assets Under Management: $125.90 million
Average Daily Volume: $14.81 million
Discount/Premium: -0.02%
Leveraged: -3.00

Administrator, Advisor and Custodian

Administrator: U.S. Bancorp Fund Services, LLC
Advisor: Rafferty Asset Management, LLC
Custodian: The Bank of New York Mellon Corporation
Distributor: Foreside Fund Services, LLC
Transfer Agent: The Bank of New York Mellon Corporation
Trustee: N/A
Lead Market Maker: Virtu Financial

Options

Optionable: Optionable
Options Volume: 2,557
Put Options: 382
Call Options: 2,175
Short Interest: 2,300,000 shs

Miscellaneous

Outstanding Shares: 14,720,000
Beta: -2.40
Creation Unit: 50,000
Creation Fee: $250.00

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Ad Chaikin Analytics

Henry Kissinger’s chilling AI warning

Not long before his death in 2023, Henry Kissinger wrote about a "world of potentially total destructiveness and substantial uncertainty." He was talking about the advent of generative artificial intelligence (AI)... And how we are woefully unprepared for the consequences this technology could bring.

Just click right here to access this new research 100% free while it’s still available.

Direxion Daily S&P Biotech Bear 3x Shares Expenses

Type	LABD	Health Care ETFs	Equity ETFs	NYSEARCA ETFs	All ETFs
Management Fee	0.75%	0.56%	0.54%	0.50%	0.51%
Other Expenses	0.26%	0.40%	0.54%	0.64%	0.58%
Total Expense	1.01%	0.72%	0.70%	0.74%	0.70%
Fee Waiver	-0.01%	-0.53%	-0.55%	-0.68%	-0.57%
Net Expense	1.00%	0.60%	0.60%	0.58%	0.58%

Direxion Daily S&P Biotech Bear 3x Shares (LABD) Holdings

Top 10 LABD Holdings

DREYFUS GOVT CASH MAN INS
Holding Weight: 47.69%
GOLDMAN FINL SQ TRSRY INST 506
Holding Weight: 38.01%
DREYFUS TRSRY SECURITIES CASH MGMT
Holding Weight: 8.49%
GOLDMAN SACHS FIN GOV 465 INSTITUT
Holding Weight: 8.49%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
Holding Weight: -34.48%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
Holding Weight: -40.92%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
Holding Weight: -42.68%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
Holding Weight: -42.73%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
Holding Weight: -61.08%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
Holding Weight: -78.11%

Full Holdings Details

Similar ETFs

Institutional Ownership

View All Institutional Transactions

LABD ETF - Frequently Asked Questions

How have LABD shares performed in 2024?: Direxion Daily S&P Biotech Bear 3x Shares' stock was trading at $9.69 at the beginning of the year. Since then, LABD shares have increased by 6.8% and is now trading at $10.35.
View the best growth stocks for 2024 here.
What does LABD invest in?: Direxion Daily S&P Biotech Bear 3x Shares is a equity fund issued by Direxion. LABD focuses on health care investments and follows the S&P Biotechnology Select Industry Index. The fund's investments total to approximately $131.24 million assets under management.
What is the management fee for Direxion Daily S&P Biotech Bear 3x Shares?: Direxion Daily S&P Biotech Bear 3x Shares' management fee is 0.75% and has other expenses of 0.26%. However, LABD has a fee waiver of -0.01% to reimburse the expenses. The net expense ratio for LABD is 1.00%.
When did Direxion Daily S&P Biotech Bear 3x Shares' stock split?: Shares of Direxion Daily S&P Biotech Bear 3x Shares reverse split on Friday, August 28th 2020. The 1-20 reverse split was announced on Monday, July 27th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 27th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Direxion Daily S&P Biotech Bear 3x Shares own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Direxion Daily S&P Biotech Bear 3x Shares investors own include Direxion Daily S&P Biotech Bull 3x Shares (LABU), Micron Technology (MU), Intel (INTC), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Pfizer (PFE), Direxion Daily Semiconductors Bull 3x Shares (SOXL) and ProShares UltraPro Short QQQ (SQQQ).
How do I buy shares of Direxion Daily S&P Biotech Bear 3x Shares?: Shares of LABD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:LABD) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial